You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

163 Results
Regimen
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Neoadjuvant, Adjuvant
Updated
Apr 2026
Regimen
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Adjuvant
Updated
Apr 2026
Drug
Other Name(s): Onivyde®
Updated
Apr 2026
Regimen
Cancer Type:
Gastrointestinal, 
Pancreas
Intent: Palliative
Updated
Apr 2026
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Intent: Palliative
Funding:
Exceptional Access Program
    Ivosidenib in combination with Azacitidine (Outpatient) - Previously Untreated Acute Myeloid Leukemia
New Drug Funding Program
    Azacitidine in combination with Ivosidenib (Outpatient) - Previously Untreated Acute Myeloid Leukemia
Updated
Apr 2026
Drug
Other Name(s): Polivy™
Updated
Apr 2026
Drug
Other Name(s): Darzalex®
Jan 2026

Pages